In this complex topic of major clinical interest, SURMOUNT-MAINTAIN now provides information on the effect of dose reduction on the maintenance of bodyweight reduction for the first time in a dedicated RCT, Scheen wrote, adding that more specific research is still warranted to determine which patients are most likely to successfully maintain weight loss on lower-dose treatment
Group LAR, Yeh HC, Bantle JP, Cassidy-Begay M, Blackburn G, Bray GA, et al
Nutritional deficiencies that quietly destroy libido during treatment Semaglutide causes significant appetite reduction
Quality control and documentation Quality Control A defensible quality review for Tirzepatide should separate identity from purity and should verify that every report maps to the received batch
The starting dose is typically low and is titrated up based on individual tolerance and weight loss response